Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

CD4 + T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation

Cor H. J. Lamers, Rebecca Wijers, Cornelis A. M. van Bergen, Judith A. E. Somers, Eric Braakman, Jan Willem Gratama, Reno Debets, J. H. Frederik Falkenburg, Jan J. Cornelissen

Blood (2016) 128 (17): 2165–2174.

https://doi.org/10.1182/blood-2016-06-718619

Published: 2016

Includes: Supplemental data

Journal Articles

Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia?

Michiel Strijbos, MD, Precious Landburg, MD, Erfan Nur, MD, Bart J. Biemond, MD, PhD, Frank Leebeek, MD, PhD, Jan-Willem Gratama, PhD, Ashley Duits, PhD, John-John Schnog, MD, PhD

Blood (2008) 112 (11): 4798.

https://doi.org/10.1182/blood.V112.11.4798.4798

Published: 2008

Journal Articles

Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

Joost W. J. van Esser, Hubert G. M. Niesters, Bronno van der Holt, Ellen Meijer, Albert D. M. E. Osterhaus, Jan Willem Gratama, Leo F. Verdonck, Bob Löwenberg, Jan J. Cornelissen

Blood (2002) 99 (12): 4364–4369.

https://doi.org/10.1182/blood.V99.12.4364

Published: 2002

Journal Articles

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

Joost W. J. van Esser, Bronno van der Holt, Ellen Meijer, Hubert G. M. Niesters, Rudolf Trenschel, Steven F. T. Thijsen, Anton M. van Loon, Francesco Frassoni, Andrea Bacigalupo, Ulrich W. Schaefer, Albert D. M. E. Osterhaus, Jan Willem Gratama, Bob Löwenberg, Leo F. Verdonck, Jan J. Cornelissen

Blood (2001) 98 (4): 972–978.

https://doi.org/10.1182/blood.V98.4.972

Published: 2001

Journal Articles

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation

Annoek E. C. Broers, Ron van der Holt, Joost W. J. van Esser, Jan-Willem Gratama, Sonja Henzen-Logmans, Vibeke Kuenen-Boumeester, Bob Löwenberg, Jan J. Cornelissen

Blood (2000) 95 (7): 2240–2245.

https://doi.org/10.1182/blood.V95.7.2240

Published: 2000

NARROW

CD4 + T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation

Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia?

Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

CD4 + T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation

Circulating Endothelial Cells: A Potential Parameter of Organ Damage in Sickle Cell Anemia?

Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only